• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synthetic Biologics Inc

+ Add to Watchlist

SYN:US

2.3100 USD 0.0100 0.43%

As of 18:40:03 ET on 08/21/2014.

Snapshot for Synthetic Biologics Inc (SYN)

Open: 2.2500 Day's Range: 2.1200 - 2.4000 Volume: 1,261,354
Previous Close: 2.3200 52wk Range: 0.9500 - 3.6400 1-Yr Rtn: +54.00%

Stock Chart for SYN

No chart data available.
  • SYN:US 2.3100
  • 1D
  • 1M
  • 1Y
2.3200
Interactive SYN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SYN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3170
Est. EPS (USD) (12/2014) -0.2350
Est. PEG Ratio -
Market Cap (M USD) 136.78
Shares Outstanding (M) 58.45
30 Day Average Volume 737,134
Price/Book (mrq) 16.7590
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SYN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SYN

Synthetic Biologics, Inc. develops synthetic DNA-based therapeutics and disease-modifying medicines. The Company developed, or participated in developing, products to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis.

Jeffrey Lucero Riley "Jeff"President/CEOC Evan BallantyneCFO/Treasurer/Secretary
More Company Profile & Key Executives for SYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil